Job description The Heart Failure Research team of Prof.dr.Stephane Heymans within CARIM and the University (Hospital) of Maastricht (
www.hfresearch.eu) is looking for (MD) PhD candidates to identify the best immune/genetic targets of non-ischemic cardiomyopathies. If you are interested in unravelling disease pathophysiology of inflammatory and/or genetic cardiomyopathies, and as such identifying new therapeutic targets, you will like this project. You will help to analyze the increasing amount of transcriptomics, proteomics and whole genome sequencing data (bulk and single cell in heart/blood) in our centre in our cohort on non-ischemic CMPs. You will unravel new targets for drug development in specific subgroups of genetic or inflammatory cardiomyopathies. Pending on your clinical and/or molecular expertise, you will drive the further development of these targets either in experimental studies (mice/ in vitro) or validate your findings in the existing human cardiac/blood samples with additional expression studies. If you have expertise/interest in data science for omics analysis, if you are passionate about a possible clinical impact, and would like to translate this to new therapies, you are the right candidate.
Projects: we have 1, by extension 2, positions available, within International (European) projects and in close collaboration with industry and the hospital.
Environment: This team has a strong combined clinical-translational-basic research expertise in nonischemic (genetic & inflammatory) cardiomyopathies, with deep phenotyped patient cohort (>2300 patients follow up of up to 20 years); with PBMC, DNA, plasma/serum, and cardiac tissue biobanking, and a long-term clinical and imaging follow-up. Our team exists of enthusiastic clinical and basic researchers/ technicians/ data scientists/ nurses. By working with us, you will understand what the impact of your work is for the patient him/herself. We have, beside the human samples and data, also mouse models, cardiac cells in vitro, iPSc cells available to identify/validate the targets in d i f f e r e n t genetic/inflammatory cardiomyopathies. We have transcriptomics (>300) and whole genome sequencing data (n=450) available. With your clinical and/our molecular expertise, and a drive data science/analysis (bio-informatics) you will have a great time, and have the opportunity to closely work together with clinicians and industry partners (Pharma and Biotech) to bring it further into the patient.